» Articles » PMID: 30446431

Fogarty International Center Collaborative Networks in Infectious Disease Modeling: Lessons Learnt in Research and Capacity Building

Overview
Journal Epidemics
Publisher Elsevier
Date 2018 Nov 18
PMID 30446431
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Due to a combination of ecological, political, and demographic factors, the emergence of novel pathogens has been increasingly observed in animals and humans in recent decades. Enhancing global capacity to study and interpret infectious disease surveillance data, and to develop data-driven computational models to guide policy, represents one of the most cost-effective, and yet overlooked, ways to prepare for the next pandemic. Epidemiological and behavioral data from recent pandemics and historic scourges have provided rich opportunities for validation of computational models, while new sequencing technologies and the 'big data' revolution present new tools for studying the epidemiology of outbreaks in real time. For the past two decades, the Division of International Epidemiology and Population Studies (DIEPS) of the NIH Fogarty International Center has spearheaded two synergistic programs to better understand and devise control strategies for global infectious disease threats. The Multinational Influenza Seasonal Mortality Study (MISMS) has strengthened global capacity to study the epidemiology and evolutionary dynamics of influenza viruses in 80 countries by organizing international research activities and training workshops. The Research and Policy in Infectious Disease Dynamics (RAPIDD) program and its precursor activities has established a network of global experts in infectious disease modeling operating at the research-policy interface, with collaborators in 78 countries. These activities have provided evidence-based recommendations for disease control, including during large-scale outbreaks of pandemic influenza, Ebola and Zika virus. Together, these programs have coordinated international collaborative networks to advance the study of emerging disease threats and the field of computational epidemic modeling. A global community of researchers and policy-makers have used the tools and trainings developed by these programs to interpret infectious disease patterns in their countries, understand modeling concepts, and inform control policies. Here we reflect on the scientific achievements and lessons learnt from these programs (h-index = 106 for RAPIDD and 79 for MISMS), including the identification of outstanding researchers and fellows; funding flexibility for timely research workshops and working groups (particularly relative to more traditional investigator-based grant programs); emphasis on group activities such as large-scale modeling reviews, model comparisons, forecasting challenges and special journal issues; strong quality control with a light touch on outputs; and prominence of training, data-sharing, and joint publications.

Citing Articles

Navigating the Nexus of Bioethics and Geopolitics: Implications for Global Health Security and Scientific Collaboration.

Klimovich-Mickael A, Sacharczuk M, Mickael M J Bioeth Inq. 2024; .

PMID: 39164608 DOI: 10.1007/s11673-024-10379-3.


Transboundary determinants of avian zoonotic infectious diseases: challenges for strengthening research capacity and connecting surveillance networks.

Fair J, Al-Hmoud N, Alrwashdeh M, Bartlow A, Balkhamishvili S, Daraselia I Front Microbiol. 2024; 15:1341842.

PMID: 38435695 PMC: 10907996. DOI: 10.3389/fmicb.2024.1341842.


Global Health Perspectives on Race in Research: Neocolonial Extraction and Local Marginalization.

Tankwanchi A, Asabor E, Vermund S Int J Environ Res Public Health. 2023; 20(13).

PMID: 37444057 PMC: 10341112. DOI: 10.3390/ijerph20136210.


A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes.

Arevalo C, Bolton M, Le Sage V, Ye N, Furey C, Muramatsu H Science. 2022; 378(6622):899-904.

PMID: 36423275 PMC: 10790309. DOI: 10.1126/science.abm0271.


Monitoring COVID-19 in Colombia during the first year of the pandemic.

Ospina J, Hincapie-Palacio D, Ochoa J, Velasquez C, Almanza Payares R J Public Health Res. 2022; 11(3):22799036221115770.

PMID: 36052098 PMC: 9425916. DOI: 10.1177/22799036221115770.


References
1.
Lessler J, Riley S, Read J, Wang S, Zhu H, Smith G . Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China. PLoS Pathog. 2012; 8(7):e1002802. PMC: 3400560. DOI: 10.1371/journal.ppat.1002802. View

2.
Yang W, Cowling B, Lau E, Shaman J . Forecasting Influenza Epidemics in Hong Kong. PLoS Comput Biol. 2015; 11(7):e1004383. PMC: 4520691. DOI: 10.1371/journal.pcbi.1004383. View

3.
Holmes E, Ghedin E, Halpin R, Stockwell T, Zhang X, Fleming R . Extensive geographical mixing of 2009 human H1N1 influenza A virus in a single university community. J Virol. 2011; 85(14):6923-9. PMC: 3126550. DOI: 10.1128/JVI.00438-11. View

4.
Chowell G, Echevarria-Zuno S, Viboud C, Simonsen L, Grajales Muniz C, Pacheco R . Recrudescent wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: Age shift and severity. PLoS Curr. 2012; 4:RRN1306. PMC: 3286879. DOI: 10.1371/currents.RRN1306. View

5.
Takahashi S, Metcalf C, Ferrari M, Moss W, Truelove S, Tatem A . Reduced vaccination and the risk of measles and other childhood infections post-Ebola. Science. 2015; 347(6227):1240-2. PMC: 4691345. DOI: 10.1126/science.aaa3438. View